Bridges Investment Management Inc Catalent, Inc. Transaction History

Bridges Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 08, 2022	SELL	$94.19 - $124.49 $1.18 Million - $1.56 Million	-12,493 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$119.57 - $139.07 $1,913 - $2,225	-16 Reduced 0.13%	12,493 $1.6 Million
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $4,694 - $6,121	-43 Reduced 0.34%	12,509 $1.67 Million
Q2 2021 Jul 19, 2021	BUY	$100.34 - $115.69 $12,642 - $14,576	126 Added 1.01%	12,552 $1.36 Million
Q1 2021 May 05, 2021	BUY	$101.51 - $125.27 $1.26 Million - $1.56 Million	12,426 New	12,426 $1.31 Million
Q4 2019 Feb 18, 2020	SELL	$47.06 - $56.64 $584,767 - $703,808	-12,426 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$39.26 - $54.21 $487,844 - $673,613	12,426 New	12,426 $674,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Bridges Investment Management Inc with notifications on news.